This is the current revision of this page, as edited by Buidhe (talk | contribs) at 20:46, 1 December 2023 (Moving from Category:Experimental drugs to Category:Experimental monoclonal antibodies using Cat-a-lot). The present address (URL) is a permanent link to this version.
Revision as of 20:46, 1 December 2023 by Buidhe (talk | contribs) (Moving from Category:Experimental drugs to Category:Experimental monoclonal antibodies using Cat-a-lot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Monoclonal antibody Pharmaceutical compound| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | cytomegalovirus glycoprotein B |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| (what is this?) (verify) | |
Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.
References
- Arizono H, Sugano T, Kaida S, Shibusawa K, Karasawa Y, Esumi Y, et al. (July 1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.
| Monoclonal antibodies for infectious disease and toxins | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fungal |
| ||||||||
| Viral | |||||||||
| Bacterial |
| ||||||||
| Toxin |
| ||||||||
| |||||||||
 | This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |
 | This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it. |